Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Pancreatic Adenocarcinoma Excision Surgery on Peripheral and Portal Circulating Tumor DNA: Prospective Exploratory Pilot Study.

NCT03435536 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT03435536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03435536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Pancreatic Adenocarcinoma Excision Surgery on Peripheral and Portal Circulating Tumor DNA: Prospective Exploratory Pilot Study.
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Completed
Start date
February 26, 2018
Completion date
June 20, 2022
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resectable pancreatic cancer